logo
[breadcrumb_custom]

Tag: ACADIA Pharmaceuticals

Equity News

Is Acadia Pharmaceuticals Inc. (ACAD) Stock Entering in Growth Territory?

The pharmaceutical firm Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) had its stock rise 15.51 percent to $18.77 in trade on June 15, thanks to the release of official statistics. The US Food and Medicine Administration (FDA) has released data that might imply that the findings of tests on the use of the drug Nuprazid for the treatment of psychosis in Alzheimer’s disease patients were favorable. In 2019, the medicine Nuplazid prompted a large double-digit spike in stock prices. There is a tremendous unmet need for the treatment of Alzheimer’s disease, or at the very least its most severe symptoms. As a